DIGESTIVE HEALTH PRODUCTS MARKET ANALYSIS

Digestive Health Market By Product Type (Probiotics, Prebiotics, Digestive Enzymes, and Others), By Indication (Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), Gastroesophageal Reflux Disease (GERD), Diarrhea and Constipation, and Others), By Age Group (Adults, Children, and Elderly), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Supermarkets and Hypermarkets), By End User (Research Institutes and Laboratories, Hospitals and Clinics, and Homecare Settings), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Recent Developments

New product launches

In 2021, IFF launches new milk product enzyme in the US. The enzyme, called LactoFerm LBC, is designed to help break down lactose in milk, thus making it easier for people with lactose intolerance to digest.
In 2020, Sanofi (multinational pharmaceutical and healthcare company) to launch Diorabyota as a replacement for its previous product. Diorabyota is a probiotic that is designed to help improve gut health and reduce the risk of diarrhea.
In August 2023, Herbalife Nutrition launches new line of digestive health products. The new line includes probiotics, prebiotics, and digestive enzymes.

Acquisition and partnerships

In 2022, GI Alliance (GIA), a private equity-backed gastroenterology platform, acquired Digestive Health Specialists, the largest independent practice in Missouri.
Also in 2022, GI Alliance (GIA) acquired Gastroenterology Consultants, a U.S.-based practice with nine physicians and six advanced practice providers
In 2021, Unio Health Partners, a healthcare services company, acquired Insite Digestive Health Care, a digestive health practice in the Midwest